Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

4.600

-0.200 (-4.17%)

At close: Feb 21, 2025, 4:00 PM

4.500

-0.100 (-2.17%)

After-hours: Feb 21, 2025, 7:03 PM EST

Trevi Therapeutics Market Cap

Trevi Therapeutics has a market cap or net worth of $411.08 million as of February 21, 2025. Its market cap has increased by 340.92% in one year.

Market Cap

411.08M

Enterprise Value

346.70M

1-Year Change

340.92%

Ranking

#3125

Market Cap Chart

Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $411.08M, an increase of 383.69%. That is a compound annual growth rate of 31.23%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	411.08M	11.65%
Dec 31, 2024	368.19M	330.28%
Dec 29, 2023	85.57M	-26.01%
Dec 30, 2022	115.65M	472.04%
Dec 31, 2021	20.22M	-54.55%
Dec 31, 2020	44.48M	-33.49%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings